Form 4 for ADIL ADIAL PHARMACEUTICALS, INC.
Accepted 2021-10-06 00:00:00 ET · period of report 2021-10-04 · accession 0001213900-21-051646 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-10-06 | 2021-10-04 | ADIL | Johnson Bankole A. | Chief Medical Off | S - Sale | — | -200.0K | 148.2K | -57% | — |
| D | 2021-10-06 | 2021-10-04 | ADIL | Johnson Bankole A. | Chief Medical Off | J - Other | — | -150.0K | 39.7K | -79% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-04 | S | D | 200,000 | — | 148,246 | I By En Fideicomiso De Mi Vida 11/23/2010 (Trust) | — | — | (F1) En Fideicomiso De Mi Vida 11/23/2010 (the "Trust") sold 200,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of October 1, 2021 (the "SPA"), for an aggregate purchase price of $200,000. (F2) Dr. Johnson is the trustee of the Trust. |
| 2 | Derivative | Warrant | 2021-10-04 | J | D | 150,000 | — | 39,714 | D | — · — to — | 150,000 Common Stock | (F3) On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance. |